XML 27 R16.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 7 - Stock-based Compensation
9 Months Ended
Sep. 30, 2017
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
7.
       Stock-Based Compensation
 
For the
three
months ended
September 30, 2017
and
2016,
the Company’s net income, as reported, includes
$1.1
million of stock-based compensation costs and
$0.4
of income tax benefits related to the stock-based compensation plans in each of the periods. For the
nine
months ended
September 30, 2017
and
2016,
the Company’s net income, as reported, includes
$5.2
million and
$4.7
million, respectively, of stock-based compensation costs and
$1.7
million and
$1.8
million, respectively, of income tax benefits related to the stock-based compensation plans. The Company did
not
issue any restricted stock units during the
three
months ended
September 30, 2017
and
2016.
During the
nine
months ended
September 30, 2017
and
2016,
the Company granted
276,900
and
337,175
restricted stock units, respectively. The Company has
not
granted stock options since
2009.
At
September 30, 2017,
the Company had
1,200
stock options, all
100%
vested, outstanding.
 
The Company uses the fair value of the common stock on the date of award to measure compensation cost for restricted stock unit awards. Compensation cost is recognized over the vesting period of the award using the straight-line method.
 
The
2014
Omnibus Incentive Plan (
“2014
Omnibus Plan”) became effective on
May 20, 2014
after adoption by the Board of Directors and approval by the stockholders. The
2014
Omnibus Plan authorizes the Compensation Committee of the Company’s Board of Directors to grant a variety of equity compensation awards as well as long-term and annual cash incentive awards, all of which can, but need
not,
be structured so as to comply with Section
162
(m) of the Internal Revenue Code of
1986,
as amended. On
May 31, 2017,
stockholders approved an amendment to the
2014
Omnibus Plan (the “Amendment”) authorizing an additional
672,000
shares available for future issuance. In addition, to increasing the number of shares for future grants, the Amendment eliminates, in the case of stock options and SARs, the ability to recycle shares used to satisfy the exercise price or taxes for such awards.
No
other amendments to the
2014
Omnibus Plan were made. Including the additional shares authorized from the Amendment,
953,268
shares are available for future issuance under the
2014
Omnibus Plan at
September 30, 2017.
 
The following table summarizes the Company’s restricted stock unit (“RSU”) awards at or for the
nine
months ended
September 30, 2017:
 
    Shares   Weighted-Average
Grant-Date
Fair Value
         
Non-vested at December 31, 2016    
488,779
    $
18.99
 
Granted    
276,900
     
28.21
 
Vested    
(244,762
)    
21.93
 
Forfeited    
(22,860
)    
23.61
 
Non-vested at September 30, 2017    
498,057
    $
22.46
 
                 
Vested but unissued at September 30, 2017    
244,077
    $
22.67
 
 
As of
September 30, 2017,
there was
$8.7
million of total unrecognized compensation cost related to RSU awards granted. That cost is expected to be recognized over a weighted-average period of
3.1
years. The total fair value of awards vested for the
three
months ended
September 30, 2017
and
2016
was
$14,000
and
$4,000,
respectively. The total fair value of awards vested for the
nine
months ended
September 30, 2017
and
2016
was
$7.0
million and
$4.8
million, respectively. The vested but unissued RSU awards consist of awards made to employees and directors who are eligible for retirement. According to the terms of these awards, which provide for vesting upon retirement, these employees and directors have
no
risk of forfeiture. These shares will be issued at the original contractual vesting and settlement dates.
 
Cash proceeds, fair value received, tax benefits, and intrinsic value related to stock options exercised, and the weighted average grant date fair value for options granted, during the
three
and
nine
months ended
September 30, 2017
and
2016
are provided in the following table:
 
 
 
 
 
For the three months ended
September 30,
 
 
For the nine months ended
September 30,
(In thousands)   2017   2016   2017   2016
Proceeds from stock options exercised   $
-
    $
5
    $
-
    $
132
 
Fair value of shares received upon exercise of stock options    
-
     
262
     
37
     
612
 
Tax benefit (expense) related to stock options exercised    
-
     
(10
)    
39
     
(12
)
Intrinsic value of stock options exercised    
-
     
44
     
96
     
156
 
 
Phantom Stock Plan:
The Company maintains a non-qualified phantom stock plan as a supplement to its profit sharing plan for officers who have achieved the designated level and completed
one
year of service. The Company adjusts its liability under this plan to the fair value of the shares at the end of each period.
 
The following table summarizes the Phantom Stock Plan at or for the
nine
months ended
September 30, 2017:
 
Phantom Stock Plan   Shares   Fair Value
         
Outstanding at December 31, 2016    
89,339
    $
29.39
 
Granted    
7,889
     
27.42
 
Forfeited    
(10
)    
28.95
 
Distributions    
(8,471
)    
28.69
 
Outstanding at September 30, 2017    
88,747
    $
29.72
 
Vested at September 30, 2017    
88,431
    $
29.72
 
 
The Company recorded stock-based compensation expense for the Phantom Stock Plan of
$0.2
million and
$0.4
million for the
three
months ended
September 30, 2017
and
2016,
respectively. The total fair value of the distributions from the Phantom Stock Plan was
$0.2
million for the
three
months ended
September 30, 2017.
There were
no
distributions for the
three
months ended
September 30, 2016.
 
For the
nine
months ended
September 30, 2017
and
2016,
the Company recorded stock-based compensation expense for the Phantom Stock Plan of
$0.1
million and
$0.2
million, respectively. The total fair value of the distributions from the Phantom Stock Plan during the
nine
months ended
September 30, 2017
and
2016
was
$0.2
million and
$28,000,
respectively.